Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (381-390 of 405) with videos related to

Pageof 41
Sort By:
European Journal of Heart Failure|April 14, 2016
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiencyStefan D Anker, Stefan Schroeder, Dan Atar, et al.
The New England Journal of Medicine|July 26, 2011
Apixaban with antiplatelet therapy after acute coronary syndromeJohn H Alexander, Renato D Lopes, Stefan James, et al.
European Journal of Heart Failure|June 22, 2016
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]Stefan D Anker, Stefan Schroeder, Dan Atar, et al.
The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
European Stroke Journal|July 2, 2019
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and designBarbara Ratajczak-Tretel, Anna Tancin Lambert, Henriette Johansen, et al.
The New England Journal of Medicine|November 12, 2023
Apixaban for Stroke Prevention in Subclinical Atrial FibrillationJeff S Healey, Renato D Lopes, Christopher B Granger, et al.
European Journal of Neurology|February 14, 2023
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) studyAnna Tancin Lambert, Barbara Ratajczak-Tretel, Riadh Al-Ani, et al.
The Lancet. Digital Health|September 1, 2022
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
BMJ (Clinical Research Ed.)|December 23, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
Pageof 41

Showing results (381-390 of 405) with videos related to

Sort By:
Pageof 41
European Journal of Heart Failure|April 14, 2016
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiencyStefan D Anker, Stefan Schroeder, Dan Atar, et al.
The New England Journal of Medicine|July 26, 2011
Apixaban with antiplatelet therapy after acute coronary syndromeJohn H Alexander, Renato D Lopes, Stefan James, et al.
European Journal of Heart Failure|June 22, 2016
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]Stefan D Anker, Stefan Schroeder, Dan Atar, et al.
The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
European Stroke Journal|July 2, 2019
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and designBarbara Ratajczak-Tretel, Anna Tancin Lambert, Henriette Johansen, et al.
The New England Journal of Medicine|November 12, 2023
Apixaban for Stroke Prevention in Subclinical Atrial FibrillationJeff S Healey, Renato D Lopes, Christopher B Granger, et al.
European Journal of Neurology|February 14, 2023
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) studyAnna Tancin Lambert, Barbara Ratajczak-Tretel, Riadh Al-Ani, et al.
The Lancet. Digital Health|September 1, 2022
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
BMJ (Clinical Research Ed.)|December 23, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
Pageof 41